Starz E, Wzorek K, Folwarski M, Kazmierczak-Siedlecka K, Stachowska L, Przewlocka K
Nutrients. 2021; 13(7).
PMID: 34206152
PMC: 8308385.
DOI: 10.3390/nu13072125.
Wang C, Feng S, Xiao Y, Pan M, Zhao J, Zhang H
Microb Biotechnol. 2020; 14(2):577-586.
PMID: 32779862
PMC: 7936310.
DOI: 10.1111/1751-7915.13651.
Lee J, dAigle J, Atadja L, Quaicoe V, Honarpisheh P, Ganesh B
Circ Res. 2020; 127(4):453-465.
PMID: 32354259
PMC: 7415518.
DOI: 10.1161/CIRCRESAHA.119.316448.
Kho Z, Lal S
Front Microbiol. 2018; 9:1835.
PMID: 30154767
PMC: 6102370.
DOI: 10.3389/fmicb.2018.01835.
Li Q, Wang C, Tang C, Li N, Li J
PLoS One. 2012; 7(4):e34939.
PMID: 22529960
PMC: 3329531.
DOI: 10.1371/journal.pone.0034939.
Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.
De Hertogh G, Aerssens J, Geboes K, Geboes K
World J Gastroenterol. 2008; 14(6):845-52.
PMID: 18240341
PMC: 2687051.
DOI: 10.3748/wjg.14.845.
Reduced mucosal antimicrobial activity in Crohn's disease of the colon.
Nuding S, Fellermann K, Wehkamp J, Stange E
Gut. 2007; 56(9):1240-7.
PMID: 17456510
PMC: 1954969.
DOI: 10.1136/gut.2006.118646.
Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis.
Zhang M, Liu B, Zhang Y, Wei H, Lei Y, Zhao L
J Clin Microbiol. 2006; 45(2):496-500.
PMID: 17151201
PMC: 1829069.
DOI: 10.1128/JCM.01720-06.
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
Conte M, Schippa S, Zamboni I, Penta M, Chiarini F, Seganti L
Gut. 2006; 55(12):1760-7.
PMID: 16648155
PMC: 1856471.
DOI: 10.1136/gut.2005.078824.
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.
Ott S, Musfeldt M, Wenderoth D, Hampe J, Brant O, Folsch U
Gut. 2004; 53(5):685-93.
PMID: 15082587
PMC: 1774050.
DOI: 10.1136/gut.2003.025403.
Dysbiosis in inflammatory bowel disease.
Tamboli C, Neut C, Desreumaux P, Colombel J
Gut. 2003; 53(1):1-4.
PMID: 14684564
PMC: 1773911.
DOI: 10.1136/gut.53.1.1.
Probiotics and inflammatory bowel disease.
Jonkers D, Stockbrugger R
J R Soc Med. 2003; 96(4):167-71.
PMID: 12668702
PMC: 539443.
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.
Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P
Gut. 2003; 52(2):237-42.
PMID: 12524406
PMC: 1774977.
DOI: 10.1136/gut.52.2.237.
T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.
Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer zum Buschenfelde K
Gut. 1999; 44(6):812-8.
PMID: 10323882
PMC: 1727529.
DOI: 10.1136/gut.44.6.812.
Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.
Favier C, Neut C, Mizon C, Cortot A, Colombel J, MIZON J
Dig Dis Sci. 1997; 42(4):817-22.
PMID: 9125655
DOI: 10.1023/a:1018876400528.
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD).
Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde K
Clin Exp Immunol. 1995; 102(3):448-55.
PMID: 8536356
PMC: 1553362.
DOI: 10.1111/j.1365-2249.1995.tb03836.x.
Pouchitis: result of microbial imbalance?.
Schouten W, van Lieshout L
Gut. 1994; 35(5):658-64.
PMID: 8200561
PMC: 1374752.
DOI: 10.1136/gut.35.5.658.
Effect of selective media on recovery of obligately anaerobic gram-negative rods from human faeces.
Antonie Van Leeuwenhoek. 1983; 49(4-5):411-6.
PMID: 6651287
Induction in rats of serum agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species by the faecal flora from patients with Crohn's disease and healthy subjects.
Hazenberg M, van de Merwe J
J Hyg (Lond). 1984; 93(2):345-8.
PMID: 6501880
PMC: 2129443.
DOI: 10.1017/s0022172400064895.
The human faecal flora and Crohn's disease.
van de Merwe J
Antonie Van Leeuwenhoek. 1984; 50(5-6):691-700.
PMID: 6397136
DOI: 10.1007/BF02386234.